Dare Bioscience Inc (DARE) Stock Price, Quote & News

Company Profile

Daré Bioscience, Inc., a biopharmaceutical company, develops therapies in the areas of contraception, reproductive health, menopause, fertility, and sexual and vaginal health in the United States. The company offers XACIATO, a lincosamide antibacterial gel for the treatment of bacterial vaginosis. It also develops Ovaprene, a hormone-free, monthly intravaginal contraceptive; Sildenafil Cream, a cream formulation of sildenafil for topical administration to the female genitalia on demand for the t...

Industry: Biotechnology

Sector: Healthcare

Phone: 858 926 7655

Website: darebioscience.com

Address:

3655 Nobel Drive, Suite 260, San Diego, United States

little_jackie Jun. 13 at 10:41 PM

$DARE You guys haven't ran out @BiotechJedi1728 yet? This guy is so full of it. Ask him about his pumping of $IKT

0 · Reply

petertradebull Jun. 11 at 3:41 PM

$DARE waiting for $35. 🚀🚀🚀

2 · Reply

F_The_short Jun. 9 at 11:46 AM

$DARE Not Fugging selling😡😡😡😡😡😡😡🖕🖕🖕🖕🖕

0 · Reply

BiotechJedi1728 Jun. 6 at 11:25 PM

$DARE https://www.linkedin.com/posts/dare-bioscience_daretoplay-npwh-isswsh-activity-7336871418195791872-ExJn?utm_source=share&utm_medium=member_ios&rcm=ACoAAACdVpABt6kGksglM6yOtoqYXdcE9HE9y_M

1 · Reply

PenkeTrading Jun. 6 at 9:29 AM

I found you an Overbought RSI (Relative Strength Index) on the daily chart of Dare Bioscience Inc. Is that bullish or bearish? $DARE #RsiOverbought #NASDAQ

0 · Reply

jlca Jun. 5 at 10:38 PM

$DARE vamooooossss

0 · Reply

Investingdude Jun. 5 at 9:00 PM

$DARE too early to celebrate but at least its moving in the right direction for once

0 · Reply

Green_Party Jun. 5 at 7:28 PM

$DARE Finally starting to wake up... next few months could be something.

0 · Reply

prismmarketview Jun. 5 at 6:05 PM

$DARE https://prismmarketview.com/dare-bioscience-teams-up-with-rosy-wellness-to-launch-female-arousal-cream-in-2025/

0 · Reply

petertradebull Jun. 5 at 4:55 PM

$DARE it’s moving 🚀🚀🚀

0 · Reply

Daré Bioscience Announces Adjournment of Annual Meeting of Stockholders

May 13, 2025, 11:13 PM EDT - 4 weeks ago

Daré Bioscience, Inc. (DARE) Q1 2025 Earnings Call Transcript

May 13, 2025, 4:01 PM EDT - 4 weeks ago

Daré Bioscience Reports First Quarter 2025 Financial Results and Provides Company Update

Mar 31, 2025, 10:14 PM EDT - 2 months ago

Daré Bioscience, Inc. (DARE) Q4 2024 Earnings Call Transcript

Mar 31, 2025, 4:01 PM EDT - 2 months ago

Daré Bioscience Reports Full Year 2024 Financial Results and Provides Company Update

Mar 24, 2025, 8:00 AM EDT - 3 months ago

Daré Bioscience to Host Full Year 2024 Financial Results and Company Update Conference Call and Webcast on March 31, 2025

Feb 6, 2025, 8:00 AM EST - 4 months ago

Daré Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Support DARE-HPV Development

Jan 9, 2025, 8:00 AM EST - 5 months ago

Daré Bioscience to Participate in the Women's Health Series at the 43rd Annual J.P. Morgan Healthcare Conference

Nov 14, 2024, 8:03 PM EST - 7 months ago

Daré Bioscience, Inc. (DARE) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 4:01 PM EST - 7 months ago

Daré Bioscience Reports Third Quarter 2024 Financial Results and Provides Company Update

Nov 7, 2024, 8:00 AM EST - 7 months ago

Daré Bioscience to Host Third Quarter 2024 Financial Results and Company Update Conference Call and Webcast on November 14, 2024

Oct 23, 2024, 12:30 PM EDT - 8 months ago

Daré Bioscience Selected to Receive $10 Million Award from ARPA-H's Sprint for Women's Health

Oct 21, 2024, 8:05 AM EDT - 8 months ago

Daré Bioscience Announces Common Stock Purchase Agreement for up to $15 Million with Lincoln Park Capital Fund, LLC

Aug 12, 2024, 8:40 PM EDT - 11 months ago

Daré Bioscience, Inc. (DARE) Q2 2024 Earnings Call Transcript

Aug 12, 2024, 4:01 PM EDT - 11 months ago

Daré Bioscience Reports Second Quarter 2024 Financial Results and Provides Company Update

Jul 19, 2024, 8:00 AM EDT - 11 months ago

Daré Bioscience Regains Compliance with Nasdaq Minimum Bid Price Rule

Jul 1, 2024, 6:54 AM EDT - 1 year ago

Biotech Executive Lisa Walters-Hoffert Joins Kiora Pharmaceuticals' Board of Directors

KPRX

Jun 27, 2024, 8:00 AM EDT - 1 year ago

Daré Bioscience Announces Reverse Stock Split

May 14, 2024, 6:30 PM EDT - 1 year ago

Daré Bioscience, Inc. (DARE) Q1 2024 Earnings Call Transcript

May 14, 2024, 8:00 AM EDT - 1 year ago

Daré Bioscience Reports First Quarter 2024 Financial Results and Provides Company Update

May 2, 2024, 8:00 AM EDT - 1 year ago

Daré Bioscience Selected as a Member of ARPA-H Investor Catalyst Hub Spoke Network

Apr 30, 2024, 7:30 AM EDT - 1 year ago

Daré Bioscience Secures $22 Million in Non-Dilutive Strategic Royalty Financing to Advance Phase 3 First-in-Category Women's Health Product Candidates through Key Catalysts

Apr 23, 2024, 8:00 AM EDT - 1 year ago

Daré Bioscience Announces Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1

Apr 11, 2024, 8:00 AM EDT - 1 year ago

Daré Bioscience Announces Publication in Contraception of Positive Efficacy and Safety Findings from a Pre-Pivotal Postcoital Test Study of Ovaprene®: an Investigational Hormone-Free Monthly Intravaginal Contraceptive

Mar 28, 2024, 8:47 PM EDT - 1 year ago

Daré Bioscience, Inc. (DARE) Q4 2023 Earnings Call Transcript

Mar 28, 2024, 8:00 AM EDT - 1 year ago

Daré Bioscience Reports Full Year 2023 Financial Results and Provides Company Update

Mar 21, 2024, 8:00 AM EDT - 1 year ago

Daré Bioscience to Host Full Year 2023 Financial Results and Company Update Conference Call and Webcast on March 28, 2024

Mar 15, 2024, 2:33 PM EDT - 1 year ago

This overlooked corner of women's health could be a $350 billion market opportunity

PFE PGNY VTGN BTMD

Jan 31, 2024, 8:00 AM EST - 1 year ago

Daré Bioscience Announces Positive End-of-Phase 2 Meeting with FDA on Development of Sildenafil Cream, 3.6% in Female Sexual Arousal Disorder and Provides Company Focus Areas for 2024

Jan 26, 2024, 4:30 PM EST - 1 year ago

Daré Bioscience Announces Executive Team and Board of Directors Changes

Jan 17, 2024, 8:00 AM EST - 1 year ago

Daré Bioscience Announces Grant to Support Biotherapeutic Product Development

Jan 4, 2024, 8:00 AM EST - 1 year ago

Daré Bioscience's DARE-LARC1 Platform Technology Achieves Proof-of-Concept Device that has Transformative Potential for Women's Health as well as in Treating a Broad Range of Diseases

Dec 26, 2023, 8:00 AM EST - 1 year ago

Daré Bioscience Secures $12 million in Royalty-backed Investment Structure

Dec 20, 2023, 8:00 AM EST - 1 year ago

Daré Bioscience Announces Positive Topline Pharmacokinetic and Exploratory Efficacy Results from the DARE-PDM1 Phase 1 Clinical Study

Dec 13, 2023, 8:00 AM EST - 1 year ago

Daré Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) to Support DARE-PTB1 Phase 1 Human Clinical Study

Nov 9, 2023, 9:56 PM EST - 1 year ago

Daré Bioscience, Inc. (DARE) Q3 2023 Earnings Call Transcript

Nov 9, 2023, 8:00 AM EST - 1 year ago

Daré Bioscience Reports Third Quarter 2023 Financial Results and Provides Company Update

Nov 6, 2023, 8:00 AM EST - 1 year ago

Daré Bioscience to Participate in Three November Conferences

Nov 1, 2023, 8:00 AM EDT - 1 year ago

Daré Bioscience Announces Additional Positive Data from Phase 2b RESPOND Study of Sildenafil Cream, 3.6% in Women and Proposed Endpoints and Patient Population for Phase 3 Program

Aug 30, 2023, 8:00 AM EDT - 1 year ago

Daré Bioscience Announces $7.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Aug 10, 2023, 8:00 AM EDT - 2 years ago

Daré Bioscience Reports Second Quarter 2023 Financial Results and Provides a Company Update

Aug 9, 2023, 8:00 AM EDT - 2 years ago

Daré Bioscience Announces Publication in The Journal of The North American Menopause Society of Positive Efficacy Findings for the Treatment of Menopausal Symptoms from a Phase 1/2 Clinical Trial of DARE-HRT1 Intravaginal Rings

Aug 3, 2023, 8:00 AM EDT - 2 years ago

Daré Bioscience to Host Second Quarter 2023 Financial Results and Company Update Conference Call and Webcast on August 10, 2023

Jul 11, 2023, 5:30 PM EDT - 2 years ago

Daré Bioscience to Present at the 9th Annual International Symposium of Drug Delivery Systems

Jun 21, 2023, 8:00 AM EDT - 2 years ago

Daré Bioscience Announces Publication in Menopause: The Journal of The North American Menopause Society of Data from Phase 1/2 Open-Label Safety and Pharmacokinetics Study of DARE-HRT1 in Healthy Postmenopausal Women

Jun 14, 2023, 8:00 AM EDT - 2 years ago

Daré Bioscience to Present at the Maxim Group Virtual Healthcare Conference

Jun 9, 2023, 8:00 AM EDT - 2 years ago

Daré Bioscience Announces Publication of Phase 1/2 Pharmacokinetic, Safety and Pharmacodynamic Data for DARE-VVA1 - a Potential New Hormone-Free Treatment for Vulvovaginal Atrophy - in Climacteric, the Journal of the International Menopause Society

May 11, 2023, 10:10 PM EDT - 2 years ago

Daré Bioscience, Inc. (DARE) Q1 2023 Earnings Call Transcript

May 11, 2023, 8:00 AM EDT - 2 years ago

Daré Bioscience Reports First Quarter 2023 Financial Results and Provides a Company Update

May 4, 2023, 8:00 AM EDT - 2 years ago

Daré Bioscience to Host First Quarter 2023 Financial Results and Company Update Conference Call and Webcast on May 11, 2023

little_jackie Jun. 13 at 10:41 PM

$DARE You guys haven't ran out @BiotechJedi1728 yet? This guy is so full of it. Ask him about his pumping of $IKT

0 · Reply

petertradebull Jun. 11 at 3:41 PM

$DARE waiting for $35. 🚀🚀🚀

2 · Reply

F_The_short Jun. 9 at 11:46 AM

$DARE Not Fugging selling😡😡😡😡😡😡😡🖕🖕🖕🖕🖕

0 · Reply

BiotechJedi1728 Jun. 6 at 11:25 PM

$DARE https://www.linkedin.com/posts/dare-bioscience_daretoplay-npwh-isswsh-activity-7336871418195791872-ExJn?utm_source=share&utm_medium=member_ios&rcm=ACoAAACdVpABt6kGksglM6yOtoqYXdcE9HE9y_M

1 · Reply

PenkeTrading Jun. 6 at 9:29 AM

I found you an Overbought RSI (Relative Strength Index) on the daily chart of Dare Bioscience Inc. Is that bullish or bearish? $DARE #RsiOverbought #NASDAQ

0 · Reply

jlca Jun. 5 at 10:38 PM

$DARE vamooooossss

0 · Reply

Investingdude Jun. 5 at 9:00 PM

$DARE too early to celebrate but at least its moving in the right direction for once

0 · Reply

Green_Party Jun. 5 at 7:28 PM

$DARE Finally starting to wake up... next few months could be something.

0 · Reply

prismmarketview Jun. 5 at 6:05 PM

$DARE https://prismmarketview.com/dare-bioscience-teams-up-with-rosy-wellness-to-launch-female-arousal-cream-in-2025/

0 · Reply

petertradebull Jun. 5 at 4:55 PM

$DARE it’s moving 🚀🚀🚀

0 · Reply

HoosierDaddy1728 Jun. 5 at 1:16 PM

$DARE Premarket 9:03, 3.46dollars. Lets hope the SEC keeps watch of criminal shorts and keeps them from artificially drive down price.

0 · Reply

F_The_short Jun. 5 at 11:19 AM

$DARE 🚀🚀🚀🚀🚀😂😂😂😂😂

0 · Reply

itscrashing Jun. 5 at 11:01 AM

$DARE 👀

0 · Reply

F_The_short Jun. 4 at 10:50 PM

$DARE 🚀🚀🚀🚀🚀🚀 He was shorting 😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂

0 · Reply

BiotechJedi1728 Jun. 4 at 5:37 PM

$DARE When this goes, going to be fast after slow build contributions like this today…June to July Ovaprene readout…could be a good month. I only came on today because of $LYEL ‘s move. Better wake up. June could be a hummer.

1 · Reply

AlertsAndNews Jun. 4 at 12:08 PM

Good morning traders. Gappers this morning include $BAOS $STSS $DARE $NCEW $MCTR Lets get it!

0 · Reply

DonCorleone77 Jun. 4 at 12:08 PM

$DARE Dare Bioscience, Rose Wellness announce strategic collaboration Dare Bioscience and Rosy Wellness, a pioneering digital platform focused on providing lifespan support for women announced a strategic collaboration to support the upcoming marketing and consumer and healthcare provider awareness campaign for Dare's DARE to PLAY Sildenafil Cream. This partnership brings together Dare's clinical expertise and innovation in women's health with Rosy's digital reach and content-driven community engagement model, which includes a community of 250K+ women. "Female sexual health remains significantly underserved, and we believe our DARE to PLAY Sildenafil Cream represents a meaningful advancement," said Sabrina Martucci Johnson, President and CEO of Dare Bioscience. "Partnering with Rosy allows us to connect with women in a trusted, authentic space that encourages open discussion and education about sexual wellness."

0 · Reply

GolfPro999 Jun. 4 at 12:07 PM

$DARE

0 · Reply

F_The_short Jun. 3 at 11:34 PM

$DARE This is for all shorts 😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂😂

0 · Reply

Green_Party May. 28 at 6:04 PM

$DARE Tons of volume yesterday (125k), similar to February when it first went below $3. Possibly some dilution- I think they sold 150k in Q1. Short of a surprise sildenafil announcement, not much to get excited about til the July Ovaprene safety evaluation.

0 · Reply

F_The_short May. 27 at 9:35 PM

$DARE 😡😡😡😡😡😡😡WTF

0 · Reply

Illbeyourdoug May. 27 at 6:46 PM

$DARE new ATLs on the way

0 · Reply

Market Cap	26.82M
Revenue (ttm)	10,000.00
Net Income (ttm)	-4.05M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-40,500.00%
Debt to Equity Ratio	0.00

Volume	36,600
Avg Vol	19,888
Day's Range	N/A - N/A
Shares Out	8.85M
Stochastic %K	11%
Beta	1.20
Analysts	Strong Sell
Price Target	$13.00